News

Pharmabiz11m
Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting
Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting: Atlanta Tuesday, May 6, 2025, 13:00 Hrs [IST] Artivion, Inc., a leading cardiac ...
Pharmabiz21m
Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM
Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM: Our Bureau, Mumbai Tuesday, May 6, 2025, 12:50 Hrs ...
Pharmabiz31m
Fujifilm India set up ‘Fujifilm Skill Club’ transforming healthcare with knowledge, collaboration, and resources
Fujifilm India set up ‘Fujifilm Skill Club’ transforming healthcare with knowledge, collaboration, and resources: Our Bureau, Bengaluru Tuesday, May 6, 2025, 12:40 Hrs [IST] F ...
Pharmabiz1h
IBA introduces QUASAR GRID3D Advantage Image Distortion Analysis System at ESTRO 2025 Congress
IBA introduces QUASAR GRID3D Advantage Image Distortion Analysis System at ESTRO 2025 Congress: Louvain-la-Neuve, Belgium Tuesday, May 6, 2025, 12:00 Hrs [IST] IBA (Ion Beam Appli ...
Pharmabiz1h
Senores Pharma acquires US FDA approved ANDA for epilepsy & migraine drug, topiramate HCl 25, 50, 100 and 200 mg tablets from Wockhardt
Senores Pharma acquires US FDA approved ANDA for epilepsy & migraine drug, topiramate HCl 25, 50, 100 and 200 mg tablets from Wockhardt: Our Bureau, New Delhi Tuesday, May 6, 2025 ...
Pharmabiz1h
Glenmark's cancer drug ISB 2001 gets fast track designation from US FDA
Glenmark's cancer drug ISB 2001 gets fast track designation from US FDA: Our Bureau, New Delhi Tuesday, May 6, 2025, 11:15 Hrs [IST] New York-based Ichnos Glenmark Innovation (IGI ...
Pharmabiz2h
Nanobiotix announces full results from completed phase 1 study evaluating JNJ-1900 (NBTXR3) in pancreatic cancer
Nanobiotix announces full results from completed phase 1 study evaluating JNJ-1900 (NBTXR3) in pancreatic cancer: Paris Tuesday, May 6, 2025, 11:00 Hrs [IST] Nanobiotix, a late-st ...
Pharmabiz3h
Veraxa Biotech inks co-discovery alliance with OmniAb for novel bispecific ADC programme
Veraxa Biotech inks co-discovery alliance with OmniAb for novel bispecific ADC programme: Zurich, Switzerland Tuesday, May 6, 2025, 10:00 Hrs [IST] Veraxa Biotech AG (Veraxa), an ...
Pharmabiz4h
Dianthus Therapeutics completes patient enrollment in phase 2 MaGic trial of DNTH103 in generalized myasthenia gravis
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, announced ...
Pharmabiz5h
FDCA reports surge in number of licenses since roll out of mDMLA App: Dr H G Koshia
Shardul Nautiyal, Mumbai Tuesday, May 6, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Delhi DCA conducts raids on wholesaler’s premises and seize counterfeit versions of Vertin tab worth Rs. 5 lakhs
Peethaambaran Kunnathoor, Chennai Tuesday, May 6, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Pulmonologists alarmed by climate-linked asthma surge, find hope in novel medications
Pulmonologists alarmed by climate-linked asthma surge, find hope in novel medications: Nandita Vijayasimha, Bengaluru Tuesday, May 6, 2025, 08:00 Hrs [IST] Pulmonologists associat ...